Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
05/2009
05/27/2009CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
05/26/2009US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
05/26/2009CA2337041C Aminomethylcarboxylic acid derivatives
05/26/2009CA2242879C Method for treating sexual dysfunctions
05/22/2009WO2009064249A1 A process for the preparation of (3ar,4s, 6r, 6as)-6-amino-2, 2- dimethyltetrahydro-3ah-cyclopenta[d] [1,3] dioxol-4-ol dibenzoyl-l-tartrate and to products of said process
05/22/2009WO2009062933A1 Process for the preparation of alkylene glycol
05/22/2009WO2009035269A3 Method of manufacturing glycerol carbonate
05/22/2009WO2009010260A3 Condensed anthranilamide insecticides
05/22/2009CA2704504A1 Process for the preparation of alkylene glycol
05/22/2009CA2704001A1 A process for the preparation of (3ar,4s, 6r, 6as)-6-amino-2, 2- dimethyltetrahydro-3ah-cyclopenta[d] [1,3] dioxol-4-ol dibenzoyl-l-tartrate and to products of said process
05/21/2009US20090131687 Method of storing and transporting vinylene carbonate
05/21/2009US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease
05/21/2009US20090130455 for attaching polypeptides, proteins, antibodies, oligonucleotides, lipids, carbohydrates to a surface; using these reagents for detecting a target compound; chemical synthesis
05/20/2009CN101437866A Novel O-carboxy anhydrides (OCAS) comprising a salifiable function and polymers obtained from these OCAS
05/20/2009CN101437808A Process for the synthesis of arylamines from the reaction ofan aromaticcompounds with ammonia or a metal amide
05/20/2009CN101434572A Prodrugs of GABA analogs, compositions and uses thereof
05/20/2009CN100488957C Use of a mixture of esters of fatty acids as fuel or solvent
05/19/2009CA2292968C Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
05/14/2009WO2009059941A1 Method for teh regioselective alkoxyalkylation of substituted benzenes
05/14/2009US20090124686 Gsk-3 inhibitors
05/13/2009EP2057149A2 Pseudobase benzo [c]phenanthridines with improved efficacy, stability, and safety
05/13/2009EP2057116A1 New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
05/13/2009EP1565429B1 Diaryl ureido derivatives and their medical use
05/13/2009CN101429181A P-hydroxybenzene acrylic acid derivative and uses thereof
05/13/2009CN100486982C Compound possessing function for preventing and curing thrombus disease, its pharmacy composition and usage in medication
05/13/2009CN100486981C Compound possessing function for preventing and curing atherosclerosis and its application in biologic pharmacological science
05/13/2009CN100486973C Novel benzodioxoles
05/12/2009US7531695 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
05/12/2009US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/07/2009WO2009056233A1 Method for the production of substituted and unsubstituted cyclohexanone monoketals
05/07/2009US20090118323 Antitumor benzoylsulfonamides
05/06/2009EP2055699A1 Process for producing cyclic carbonates
05/06/2009EP2055693A1 Method for manufacturing substituted and unsubstituted cyclohexanone monoketales
05/06/2009EP2054368A2 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
05/05/2009US7528167 Inhibitors of papilloma virus
05/05/2009CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
04/2009
04/30/2009US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
04/30/2009US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex
04/30/2009US20090110796 Aromatic neomenthylamides as flavoring substances
04/29/2009EP1511472B1 Compounds useful in the treatment of anthrax and inhibiting lethal factor
04/29/2009CN101421230A Novel phenyl-propargylether derivatives
04/29/2009CN101417994A Method for producing 4-(3',4'-methylenedioxy)phenyl-2-butanone
04/29/2009CN101417993A Preparation method of vinylene carbonate and method for converting the same to vinylene carbonate
04/29/2009CN100482649C Organic compounds
04/28/2009US7524976 Process for preparing difluorobenzo-1,3-dioxole-5-carboxylic acid derivatives
04/28/2009US7524956 Hemisynthetic method and new compounds
04/28/2009US7524873 Substituted N-phenylmethyl ethanamines; N-((6-(methyloxy)-4'-(trifluoromethyl)-1,1'-biphenyl-3-yl)methyl)-1-(1-naphthalenyl)ethanamine; parathyroid hormone inhibitors; antisecretory agents; osteoporosis
04/28/2009US7524846 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders
04/28/2009CA2400176C Substituted piperazine compounds
04/28/2009CA2361716C Method of preparing alkylated salicylamides
04/28/2009CA2339765C Compounds and compositions for delivering active agents
04/28/2009CA2259922C Calcium receptor active compounds
04/23/2009WO2009052191A1 Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
04/23/2009WO2009050365A2 Method for preparing (poly)aminoalkylaminoacetamide derivatives of epipodophyllotoxin, which can be used in therapeutics as an anticancer agent
04/23/2009WO2009050352A2 Imidazolone derivatives, preparation method thereof and biological use of same
04/23/2009US20090105474 Novel anthranilic acid derivative or salt thereof
04/23/2009US20090105237 Cooling compounds
04/23/2009CA2694377A1 Imidazolone derivatives, preparation method thereof and biological use of same
04/22/2009EP2049623A2 Preparation of fatty acid esters of glycerol formal and its use as biofuel
04/22/2009EP1851193B1 Hiv protease inhibitors
04/22/2009EP1836231B1 Fluorinated polymers, method for producing the fluorinated compounds and polymers
04/22/2009EP1585757A4 Peptide deformylase inhibitors
04/21/2009US7521480 Such as 2-[3-(3-Bromo-phenyl)-ureido]-4-chloro-5-methyl-benzenesulfonic acid which is selective and non-competitive antagonist of ionotropic GluR5 receptor
04/21/2009US7521476 Aminoacetonitrile derivatives suitable for controlling parasites
04/21/2009US7521445 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands
04/21/2009US7521062 Thiosemicarbazones as anti-virals and immunopotentiators
04/16/2009WO2009026348A3 Antifungal agents from a streptomycete
04/16/2009WO2003082205A3 Compounds and methods
04/16/2009US20090099239 Antiviral Compounds and Methods
04/16/2009US20090095628 Cleavable surfactants
04/15/2009EP2046770A1 Process for the preparation of alkylene carbonate
04/15/2009EP2046147A1 Method of using organic compounds
04/15/2009EP1674461B1 Fluorine-containing dioxolane compounds and fluorine-containing polymers
04/15/2009CN101407509A Method for preparing myristicin from sinkiang Ligusticum sinense
04/15/2009CN101407508A Method for synthesizing vinylene carbonate
04/15/2009CN100478338C Process for preparing annular carbonate
04/15/2009CN100477992C Substituted piperazine and piperidine calcium channel blockers
04/14/2009US7517988 N-hydroxy-4-[2-(benzofuran-2-ylcarbonylamino)ethylsulfonyl]-benzamide; hepatitis C; inhibitors of histone deacetylase
04/14/2009US7517907 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin
04/14/2009US7517896 e.g. methyl 4-{[(5-ethoxy-5-oxopentyl)(2-methoxyphenethyl)amino]methyl}benzoate; stimulant of guanylate cyclase; catalyse the biosynthesis of cGMP from guanosine triphosphate (GTP); cardiovascular disorders; liver fibrosis
04/14/2009CA2138533C Drugs that enhance synaptic responses mediated by ampa receptors
04/09/2009WO2005054429A3 Synthesis of the c1-c6 keto-acid synthon of the epothilones
04/09/2009WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
04/08/2009EP2045249A1 Process for preparing monochloroethylene carbonate and subsequent conversion to vinylene carbonate
04/08/2009CN100475822C Synthesis method for producing ecteinascidin compound
04/08/2009CN100475206C Compounds useful in the treatment of anthrax and inhibiting lethal factor
04/07/2009US7514572 Spiro ortho ester-ether-substituted furocoumarins derived from citrus fruits, especially grapefruit; nontoxic
04/07/2009US7514475 Benzylamine analogues
04/07/2009CA2276278C Amine compounds, their production and use
04/01/2009EP2042478A1 Method for producing -diaryl electron-withdrawing group substituted compound
04/01/2009EP2041062A1 Aromachemicals
04/01/2009EP1082308B1 Heterocyclically substituted amides used as calpain inhibitors
04/01/2009CN101400667A Method of purifying ethylene carbonate, process for producing purified ethylene carbonate and ethylene carbonate
04/01/2009CN100473650C Method for preparing dihydro safrole
04/01/2009CN100473644C 9-substituted minocycline compounds
04/01/2009CN100473642C Preparation method of alpha-alkyl-isoserine and byproduct
04/01/2009CN100473638C Process for producing optically active fluorochemical
03/2009
03/31/2009US7511144 Reverse hydroxamic acid derivatives
03/31/2009US7511066 Antithrombotic aromatic ethers
03/31/2009CA2458679C Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives
1 ... 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 ... 183